Home > > > > > Report Detail

Migraine Drugs - Global Market Insights and Sales Trends 2024

Publisher Name :
Date: 25-Dec-2023
No. of pages: 118
Inquire Before Buying

The global Migraine Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Migraine Drugs in various end use industries. The expanding demands from the Hospitals, Clinics, Household Use and Others, are propelling Migraine Drugs market. Sumatriptan, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Zolmitriptan segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Migraine Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Migraine Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Migraine Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Migraine Drugs sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Migraine Drugs covered in this report include Allergan, Merck, Pfizer, Teva, Pfizer, Johnson & Johnson, Endo International, GlaxoSmithKline and Impax, etc.

The global Migraine Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

- Allergan

- Merck

- Pfizer

- Teva

- Pfizer

- Johnson & Johnson

- Endo International

- GlaxoSmithKline

- Impax

- Abbott

- Bayer

- Eli Lilly

- Ethypharm

- Kowa Pharmaceuticals America

- Winston Pharmaceuticals

- AstraZeneca

Global Migraine Drugs market, By Region:

- North America (U.S., Canada, Mexico)

- Europe (Germany, France, UK, Italy, etc.)

- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

- South America (Brazil, etc.)

- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Migraine Drugs market, Segment by Type:

- Sumatriptan

- Zolmitriptan

- Rizatriptan

- Others Drug

Global Migraine Drugs market, by Application

- Hospitals

- Clinics

- Household Use

- Others

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter Two: Detailed analysis of Migraine Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Three: Sales, revenue of Migraine Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Analysis of sales channel, distributors and customers.

Chapter Thirteen: Research Findings and Conclusion.

Migraine Drugs - Global Market Insights and Sales Trends 2024

Table of Contents
1 Migraine Drugs Market Overview
1.1 Migraine Drugs Product Overview
1.2 Migraine Drugs Market Segment by Type
1.2.1 Sumatriptan
1.2.2 Zolmitriptan
1.2.3 Rizatriptan
1.2.4 Others Drug
1.3 Global Migraine Drugs Market Size by Type
1.3.1 Global Migraine Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Migraine Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Migraine Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Migraine Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Migraine Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Migraine Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Migraine Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Migraine Drugs Sales Breakdown by Type (2018-2023)
2 Global Migraine Drugs Market Competition by Company
2.1 Global Top Players by Migraine Drugs Sales (2018-2023)
2.2 Global Top Players by Migraine Drugs Revenue (2018-2023)
2.3 Global Top Players by Migraine Drugs Price (2018-2023)
2.4 Global Top Manufacturers Migraine Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Migraine Drugs Market Competitive Situation and Trends
2.5.1 Migraine Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Migraine Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Migraine Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Migraine Drugs Market
2.8 Key Manufacturers Migraine Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Migraine Drugs Status and Outlook by Region
3.1 Global Migraine Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Migraine Drugs Historic Market Size by Region
3.2.1 Global Migraine Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Migraine Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Migraine Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Migraine Drugs Forecasted Market Size by Region
3.3.1 Global Migraine Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Migraine Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Migraine Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Migraine Drugs by Application
4.1 Migraine Drugs Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Household Use
4.1.4 Others
4.2 Global Migraine Drugs Market Size by Application
4.2.1 Global Migraine Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Migraine Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Migraine Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Migraine Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Migraine Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Migraine Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Migraine Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Migraine Drugs Sales Breakdown by Application (2018-2023)
5 North America Migraine Drugs by Country
5.1 North America Migraine Drugs Historic Market Size by Country
5.1.1 North America Migraine Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Migraine Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Migraine Drugs Sales in Value by Country (2018-2023)
5.2 North America Migraine Drugs Forecasted Market Size by Country
5.2.1 North America Migraine Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Migraine Drugs Sales in Value by Country (2024-2029)
6 Europe Migraine Drugs by Country
6.1 Europe Migraine Drugs Historic Market Size by Country
6.1.1 Europe Migraine Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Migraine Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Migraine Drugs Sales in Value by Country (2018-2023)
6.2 Europe Migraine Drugs Forecasted Market Size by Country
6.2.1 Europe Migraine Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Migraine Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Migraine Drugs by Region
7.1 Asia-Pacific Migraine Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Migraine Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Migraine Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Migraine Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Migraine Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Migraine Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Migraine Drugs Sales in Value by Region (2024-2029)
8 Latin America Migraine Drugs by Country
8.1 Latin America Migraine Drugs Historic Market Size by Country
8.1.1 Latin America Migraine Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Migraine Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Migraine Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Migraine Drugs Forecasted Market Size by Country
8.2.1 Latin America Migraine Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Migraine Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Migraine Drugs by Country
9.1 Middle East and Africa Migraine Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Migraine Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Migraine Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Migraine Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Migraine Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Migraine Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Migraine Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Allergan
10.1.1 Allergan Company Information
10.1.2 Allergan Introduction and Business Overview
10.1.3 Allergan Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Allergan Migraine Drugs Products Offered
10.1.5 Allergan Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Migraine Drugs Products Offered
10.2.5 Merck Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Migraine Drugs Products Offered
10.3.5 Pfizer Recent Development
10.4 Teva
10.4.1 Teva Company Information
10.4.2 Teva Introduction and Business Overview
10.4.3 Teva Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Teva Migraine Drugs Products Offered
10.4.5 Teva Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer Migraine Drugs Products Offered
10.5.5 Pfizer Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Johnson & Johnson Migraine Drugs Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 Endo International
10.7.1 Endo International Company Information
10.7.2 Endo International Introduction and Business Overview
10.7.3 Endo International Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Endo International Migraine Drugs Products Offered
10.7.5 Endo International Recent Development
10.8 GlaxoSmithKline
10.8.1 GlaxoSmithKline Company Information
10.8.2 GlaxoSmithKline Introduction and Business Overview
10.8.3 GlaxoSmithKline Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 GlaxoSmithKline Migraine Drugs Products Offered
10.8.5 GlaxoSmithKline Recent Development
10.9 Impax
10.9.1 Impax Company Information
10.9.2 Impax Introduction and Business Overview
10.9.3 Impax Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Impax Migraine Drugs Products Offered
10.9.5 Impax Recent Development
10.10 Abbott
10.10.1 Abbott Company Information
10.10.2 Abbott Introduction and Business Overview
10.10.3 Abbott Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Abbott Migraine Drugs Products Offered
10.10.5 Abbott Recent Development
10.11 Bayer
10.11.1 Bayer Company Information
10.11.2 Bayer Introduction and Business Overview
10.11.3 Bayer Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Bayer Migraine Drugs Products Offered
10.11.5 Bayer Recent Development
10.12 Eli Lilly
10.12.1 Eli Lilly Company Information
10.12.2 Eli Lilly Introduction and Business Overview
10.12.3 Eli Lilly Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Eli Lilly Migraine Drugs Products Offered
10.12.5 Eli Lilly Recent Development
10.13 Ethypharm
10.13.1 Ethypharm Company Information
10.13.2 Ethypharm Introduction and Business Overview
10.13.3 Ethypharm Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Ethypharm Migraine Drugs Products Offered
10.13.5 Ethypharm Recent Development
10.14 Kowa Pharmaceuticals America
10.14.1 Kowa Pharmaceuticals America Company Information
10.14.2 Kowa Pharmaceuticals America Introduction and Business Overview
10.14.3 Kowa Pharmaceuticals America Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Kowa Pharmaceuticals America Migraine Drugs Products Offered
10.14.5 Kowa Pharmaceuticals America Recent Development
10.15 Winston Pharmaceuticals
10.15.1 Winston Pharmaceuticals Company Information
10.15.2 Winston Pharmaceuticals Introduction and Business Overview
10.15.3 Winston Pharmaceuticals Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Winston Pharmaceuticals Migraine Drugs Products Offered
10.15.5 Winston Pharmaceuticals Recent Development
10.16 AstraZeneca
10.16.1 AstraZeneca Company Information
10.16.2 AstraZeneca Introduction and Business Overview
10.16.3 AstraZeneca Migraine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.16.4 AstraZeneca Migraine Drugs Products Offered
10.16.5 AstraZeneca Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Migraine Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Migraine Drugs Industrial Chain Analysis
11.4 Migraine Drugs Market Dynamics
11.4.1 Migraine Drugs Industry Trends
11.4.2 Migraine Drugs Market Drivers
11.4.3 Migraine Drugs Market Challenges
11.4.4 Migraine Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Migraine Drugs Distributors
12.3 Migraine Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Major Company of Sumatriptan
Table 2. Major Company of Zolmitriptan
Table 3. Major Company of Rizatriptan
Table 4. Major Company of Others Drug
Table 5. Global Migraine Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Migraine Drugs Sales by Type (2018-2023) & (K Pcs)
Table 7. Global Migraine Drugs Sales Market Share in Volume by Type (2018-2023)
Table 8. Global Migraine Drugs Sales by Type (2018-2023) & (US& Million)
Table 9. Global Migraine Drugs Market Share in Value by Type (2018-2023)
Table 10. Global Migraine Drugs Price by Type (2018-2023) & (USD/Pcs)
Table 11. Global Migraine Drugs Sales by Type (2024-2029) & (K Pcs)
Table 12. Global Migraine Drugs Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Migraine Drugs Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Migraine Drugs Sales Market Share in Value by Type (2024-2029)
Table 15. Global Migraine Drugs Price by Type (2024-2029) & (USD/Pcs)
Table 16. North America Migraine Drugs Sales by Type (2018-2023) & (K Pcs)
Table 17. North America Migraine Drugs Sales by Type (2018-2023) & (US$ Million)
Table 18. Europe Migraine Drugs Sales (K Pcs) by Type (2018-2023)
Table 19. Europe Migraine Drugs Sales by Type (2018-2023) & (US$ Million)
Table 20. Asia-Pacific Migraine Drugs Sales (K Pcs) by Type (2018-2023)
Table 21. Asia-Pacific Migraine Drugs Sales by Type (2018-2023) & (US$ Million)
Table 22. Latin America Migraine Drugs Sales (K Pcs) by Type (2018-2023)
Table 23. Latin America Migraine Drugs Sales by Type (2018-2023) & (US$ Million)
Table 24. Middle East and Africa Migraine Drugs Sales (K Pcs) by Type (2018-2023)
Table 25. Middle East and Africa Migraine Drugs Sales by Type (2018-2023) & (US$ Million)
Table 26. Global Migraine Drugs Sales by Company (2018-2023) & (K Pcs)
Table 27. Global Migraine Drugs Sales Share by Company (2018-2023)
Table 28. Global Migraine Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 29. Global Migraine Drugs Revenue Share by Company (2018-2023)
Table 30. Global Market Migraine Drugs Price by Company (2018-2023) & (USD/Pcs)
Table 31. Global Migraine Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Migraine Drugs as of 2022)
Table 34. Date of Key Manufacturers Enter into Migraine Drugs Market
Table 35. Key Manufacturers Migraine Drugs Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Migraine Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Migraine Drugs Sales by Region (2018-2023) & (K Pcs)
Table 39. Global Migraine Drugs Sales Market Share in Volume by Region (2018-2023)
Table 40. Global Migraine Drugs Sales by Region (2018-2023) & (US$ Million)
Table 41. Global Migraine Drugs Sales Market Share in Value by Region (2018-2023)
Table 42. Global Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 43. Global Migraine Drugs Sales by Region (2024-2029) & (K Pcs)
Table 44. Global Migraine Drugs Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Migraine Drugs Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Migraine Drugs Sales Market Share in Value by Region (2024-2029)
Table 47. Global Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2029)
Table 48. Global Migraine Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Migraine Drugs Sales by Application (2018-2023) & (K Pcs)
Table 50. Global Migraine Drugs Sales Market Share in Volume by Application (2018-2023)
Table 51. Global Migraine Drugs Sales by Application (2018-2023) & (US$ Million)
Table 52. Global Migraine Drugs Sales Market Share in Value by Application (2018-2023)
Table 53. Global Migraine Drugs Price by Application (2018-2023) & (USD/Pcs)
Table 54. Global Migraine Drugs Sales by Application (2024-2029) & (K Pcs)
Table 55. Global Migraine Drugs Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Migraine Drugs Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Migraine Drugs Sales Market Share in Value by Application (2024-2029)
Table 58. Global Migraine Drugs Price by Application (2024-2029) & (USD/Pcs)
Table 59. North America Migraine Drugs Sales by Application (2018-2023) (K Pcs)
Table 60. North America Migraine Drugs Sales by Application (2018-2023) & (US$ Million)
Table 61. Europe Migraine Drugs Sales by Application (2018-2023) (K Pcs)
Table 62. Europe Migraine Drugs Sales by Application (2018-2023) & (US$ Million)
Table 63. Asia-Pacific Migraine Drugs Sales by Application (2018-2023) (K Pcs)
Table 64. Asia-Pacific Migraine Drugs Sales by Application (2018-2023) & (US$ Million)
Table 65. Latin America Migraine Drugs Sales by Application (2018-2023) (K Pcs)
Table 66. Latin America Migraine Drugs Sales by Application (2018-2023) & (US$ Million)
Table 67. Middle East and Africa Migraine Drugs Sales by Application (2018-2023) (K Pcs)
Table 68. Middle East and Africa Migraine Drugs Sales by Application (2018-2023) & (US$ Million)
Table 69. North America Migraine Drugs Sales by Country (2018-2023) & (K Pcs)
Table 70. North America Migraine Drugs Sales Market Share in Volume by Country (2018-2023)
Table 71. North America Migraine Drugs Sales by Country (2018-2023) & (US$ Million)
Table 72. North America Migraine Drugs Sales Market Share in Value by Country (2018-2023)
Table 73. North America Migraine Drugs Sales by Country (2024-2029) & (K Pcs)
Table 74. North America Migraine Drugs Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Migraine Drugs Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Migraine Drugs Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Migraine Drugs Sales by Country (2018-2023) & (K Pcs)
Table 78. Europe Migraine Drugs Sales Market Share in Volume by Country (2018-2023)
Table 79. Europe Migraine Drugs Sales by Country (2018-2023) & (US$ Million)
Table 80. Europe Migraine Drugs Sales Market Share in Value by Country (2018-2023)
Table 81. Europe Migraine Drugs Sales by Country (2024-2029) & (K Pcs)
Table 82. Europe Migraine Drugs Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Migraine Drugs Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Migraine Drugs Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Migraine Drugs Sales by Region (2018-2023) & (K Pcs)
Table 86. Asia-Pacific Migraine Drugs Sales Market Share in Volume by Region (2018-2023)
Table 87. Asia-Pacific Migraine Drugs Sales by Region (2018-2023) & (US$ Million)
Table 88. Asia-Pacific Migraine Drugs Sales Market Share in Value by Region (2018-2023)
Table 89. Asia-Pacific Migraine Drugs Sales by Region (2024-2029) & (K Pcs)
Table 90. Asia-Pacific Migraine Drugs Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Migraine Drugs Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Migraine Drugs Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Migraine Drugs Sales by Country (2018-2023) & (K Pcs)
Table 94. Latin America Migraine Drugs Sales Market Share in Volume by Country (2018-2023)
Table 95. Latin America Migraine Drugs Sales by Country (2018-2023) & (US$ Million)
Table 96. Latin America Migraine Drugs Sales Market Share in Value by Country (2018-2023)
Table 97. Latin America Migraine Drugs Sales by Country (2024-2029) & (K Pcs)
Table 98. Latin America Migraine Drugs Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Migraine Drugs Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Migraine Drugs Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Migraine Drugs Sales by Country (2018-2023) & (K Pcs)
Table 102. Middle East and Africa Migraine Drugs Sales Market Share in Volume by Country (2018-2023)
Table 103. Middle East and Africa Migraine Drugs Sales by Country (2018-2023) & (US$ Million)
Table 104. Middle East and Africa Migraine Drugs Sales Market Share in Value by Country (2018-2023)
Table 105. Middle East and Africa Migraine Drugs Sales by Country (2024-2029) & (K Pcs)
Table 106. Middle East and Africa Migraine Drugs Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Migraine Drugs Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Migraine Drugs Sales Market Share in Value by Country (2024-2029)
Table 109. Allergan Company Information
Table 110. Allergan Introduction and Business Overview
Table 111. Allergan Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 112. Allergan Migraine Drugs Product
Table 113. Allergan Recent Development
Table 114. Merck Company Information
Table 115. Merck Introduction and Business Overview
Table 116. Merck Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 117. Merck Migraine Drugs Product
Table 118. Merck Recent Development
Table 119. Pfizer Company Information
Table 120. Pfizer Introduction and Business Overview
Table 121. Pfizer Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 122. Pfizer Migraine Drugs Product
Table 123. Pfizer Recent Development
Table 124. Teva Company Information
Table 125. Teva Introduction and Business Overview
Table 126. Teva Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 127. Teva Migraine Drugs Product
Table 128. Teva Recent Development
Table 129. Pfizer Company Information
Table 130. Pfizer Introduction and Business Overview
Table 131. Pfizer Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 132. Pfizer Migraine Drugs Product
Table 133. Pfizer Recent Development
Table 134. Johnson & Johnson Company Information
Table 135. Johnson & Johnson Introduction and Business Overview
Table 136. Johnson & Johnson Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 137. Johnson & Johnson Migraine Drugs Product
Table 138. Johnson & Johnson Recent Development
Table 139. Endo International Company Information
Table 140. Endo International Introduction and Business Overview
Table 141. Endo International Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 142. Endo International Migraine Drugs Product
Table 143. Endo International Recent Development
Table 144. GlaxoSmithKline Company Information
Table 145. GlaxoSmithKline Introduction and Business Overview
Table 146. GlaxoSmithKline Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 147. GlaxoSmithKline Migraine Drugs Product
Table 148. GlaxoSmithKline Recent Development
Table 149. Impax Company Information
Table 150. Impax Introduction and Business Overview
Table 151. Impax Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 152. Impax Migraine Drugs Product
Table 153. Impax Recent Development
Table 154. Abbott Company Information
Table 155. Abbott Introduction and Business Overview
Table 156. Abbott Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 157. Abbott Migraine Drugs Product
Table 158. Abbott Recent Development
Table 159. Bayer Company Information
Table 160. Bayer Introduction and Business Overview
Table 161. Bayer Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 162. Bayer Migraine Drugs Product
Table 163. Bayer Recent Development
Table 164. Eli Lilly Company Information
Table 165. Eli Lilly Introduction and Business Overview
Table 166. Eli Lilly Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 167. Eli Lilly Migraine Drugs Product
Table 168. Eli Lilly Recent Development
Table 169. Ethypharm Company Information
Table 170. Ethypharm Introduction and Business Overview
Table 171. Ethypharm Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 172. Ethypharm Migraine Drugs Product
Table 173. Ethypharm Recent Development
Table 174. Kowa Pharmaceuticals America Company Information
Table 175. Kowa Pharmaceuticals America Introduction and Business Overview
Table 176. Kowa Pharmaceuticals America Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 177. Kowa Pharmaceuticals America Migraine Drugs Product
Table 178. Kowa Pharmaceuticals America Recent Development
Table 179. Winston Pharmaceuticals Company Information
Table 180. Winston Pharmaceuticals Introduction and Business Overview
Table 181. Winston Pharmaceuticals Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 182. Winston Pharmaceuticals Migraine Drugs Product
Table 183. Winston Pharmaceuticals Recent Development
Table 184. AstraZeneca Company Information
Table 185. AstraZeneca Introduction and Business Overview
Table 186. AstraZeneca Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 187. AstraZeneca Migraine Drugs Product
Table 188. AstraZeneca Recent Development
Table 189. Key Raw Materials Lists
Table 190. Raw Materials Key Suppliers Lists
Table 191. Migraine Drugs Market Trends
Table 192. Migraine Drugs Market Drivers
Table 193. Migraine Drugs Market Challenges
Table 194. Migraine Drugs Market Restraints
Table 195. Migraine Drugs Distributors List
Table 196. Migraine Drugs Downstream Customers
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Migraine Drugs Product Picture
Figure 2. Global Migraine Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Migraine Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Migraine Drugs Sales Status and Outlook (2018-2029) & (K Pcs)
Figure 5. Product Picture of Sumatriptan
Figure 6. Global Sumatriptan Sales YoY Growth (2018-2029) & (K Pcs)
Figure 7. Product Picture of Zolmitriptan
Figure 8. Global Zolmitriptan Sales YoY Growth (2018-2029) & (K Pcs)
Figure 9. Product Picture of Rizatriptan
Figure 10. Global Rizatriptan Sales YoY Growth (2018-2029) & (K Pcs)
Figure 11. Product Picture of Others Drug
Figure 12. Global Others Drug Sales YoY Growth (2018-2029) & (K Pcs)
Figure 13. Global Migraine Drugs Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Migraine Drugs Sales Market Share by Type in 2022 & 2029
Figure 15. North America Migraine Drugs Sales Market Share in Volume by Type in 2022
Figure 16. North America Migraine Drugs Sales Market Share in Value by Type in 2022
Figure 17. Europe Migraine Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Europe Migraine Drugs Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Migraine Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Migraine Drugs Sales Market Share in Value by Type in 2022
Figure 21. Latin America Migraine Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Migraine Drugs Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Migraine Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Migraine Drugs Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Migraine Drugs Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Migraine Drugs Revenue in 2022
Figure 27. Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospitals
Figure 29. Global Hospitals Sales YoY Growth (2018-2029) & (K Pcs)
Figure 30. Product Picture of Clinics
Figure 31. Global Clinics Sales YoY Growth (2018-2029) & (K Pcs)
Figure 32. Product Picture of Household Use
Figure 33. Global Household Use Sales YoY Growth (2018-2029) & (K Pcs)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2029) & (K Pcs)
Figure 36. Global Migraine Drugs Sales by Application (2018-2029) & (US$ Million)
Figure 37. Global Migraine Drugs Sales Market Share by Application in 2022 & 2029
Figure 38. North America Migraine Drugs Sales Market Share in Volume by Application in 2022
Figure 39. North America Migraine Drugs Sales Market Share in Value by Application in 2022
Figure 40. Europe Migraine Drugs Sales Market Share in Volume by Application in 2022
Figure 41. Europe Migraine Drugs Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Migraine Drugs Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Migraine Drugs Sales Market Share in Value by Application in 2022
Figure 44. Latin America Migraine Drugs Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Migraine Drugs Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Migraine Drugs Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Migraine Drugs Manufacturing Cost Structure
Figure 49. Migraine Drugs Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
  • Global Narcolepsy Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 80
    According to our LPI (LP Information) latest study, the global Narcolepsy Drug market size was valued at US$ 2715.1 million in 2023. With growing demand in downstream market, the Narcolepsy Drug is forecast to a readjusted size of US$ 5598.9 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Narcolepsy Drug market. Narcolepsy Drug are expected to show stable growth in the future market. However, product differentia......
  • Global Epilepsy Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 121
    Market Overview of Global Epilepsy Drugs market: According to our latest research, the global Epilepsy Drugs market looks promising in the next 5 years. As of 2022, the global Epilepsy Drugs market was estimated at USD 4815.92 million, and it's anticipated to reach USD 6053.85 million in 2028, with a CAGR of 3.89% during the forecast years. Anti-epileptic drugs can eliminate or reduce seizures in two ways. One is to affect central neurons to prevent or reduce their pathologic......
  • Global Neuromyelitis Optica Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Neuromyelitis Optica Drug market size was valued at US$ 46 million in 2023. With growing demand in downstream market, the Neuromyelitis Optica Drug is forecast to a readjusted size of US$ 57 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Neuromyelitis Optica Drug market. Neuromyelitis Optica Drug are expected to show stable growth in the future marke......
  • Migraine Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118
    The global Migraine Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Migraine Drugs in various end use industries. The expanding demands from the Hospitals, Clinics, Household Use and Others, are propelling Migraine Drugs market. Sumatriptan, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......
  • Global Neuromyelitis Optica Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 121
    Market Overview of Global Neuromyelitis Optica Drug market: According to our latest research, the global Neuromyelitis Optica Drug market looks promising in the next 5 years. As of 2022, the global Neuromyelitis Optica Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • Global Narcolepsy Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Narcolepsy Drug market: According to our latest research, the global Narcolepsy Drug market looks promising in the next 5 years. As of 2022, the global Narcolepsy Drug market was estimated at USD 2915.59 million, and it's anticipated to reach USD 5983.81 million in 2028, with a CAGR of 12.73% during the forecast years. Narcolepsy is a neurological disorder characterized by the brain's inability to control sleep/wakefulness cycles. This......
  • Global Edaravone Market Research Report 2023
    Published: 05-Dec-2023        Price: US 2900 Onwards        Pages: 88
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Edaravone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Mitsubishi Tanabe Pharma - Simcere - Taj Pharmaceuticals Ltd. - Sun Pharmaceutical Industries Ltd. - Unichem Laboratories Ltd - UCB India Ltd - Piram......
  • Global Ethoxyquin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Ethoxyquin market: According to our latest research, the global Ethoxyquin market looks promising in the next 5 years. As of 2022, the global Ethoxyquin market was estimated at USD 216.07 million, and it's anticipated to reach USD 303.42 million in 2028, with a CAGR of 5.82% during the forecast years. Ethoxyquin (EQ) is a clear, viscous, light yellow to dark brown liquid, with an unpleasant, mercaptan-like smell, that causes irritation of the skin an......
  • Global Antipsychotic Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Oct-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Antipsychotic Drugs market: According to our latest research, the global Antipsychotic Drugs market looks promising in the next 5 years. As of 2022, the global Antipsychotic Drugs market was estimated at USD 15363.6 million, and it's anticipated to reach USD 23658.8 million in 2028, with a CAGR of 7.46% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global An......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs